C. Anthony Hunt
C. Anthony Hunt
Professor of Bioengineering and Therapeutic Sciences
Verified email at ucsf.edu
Title
Cited by
Cited by
Year
Preparation of liposomes of defined size distribution by extrusion through polycarbonate membranes
F Olson, CA Hunt, FC Szoka, WJ Vail, D Papahadjopoulos
Biochimica et Biophysica Acta (BBA)-Biomembranes 557 (1), 9-23, 1979
13741979
In vivo oligonucleotide generator, and methods of testing the binding affinity of triplex forming oligonucleotides derived therefrom
SB Noonberg, CA Hunt
US Patent 5,624,803, 1997
4811997
Liposome disposition in vivo: III. Dose and vesicle-size effects
RM Abra, CA Hunt
Biochimica et Biophysica Acta (BBA)-Lipids and Lipid Metabolism 666 (3), 493-503, 1981
3231981
Tolerance and disposition of tetrahydrocannabinol in man.
CA Hunt, RT Jones
Journal of Pharmacology and Experimental Therapeutics 215 (1), 35-44, 1980
2711980
Physicochemical properties, solubility, and protein binding of Δ9 ‐tetrahydrocannabinol
ER Garrett, CA Hunt
Journal of pharmaceutical sciences 63 (7), 1056-1064, 1974
2631974
Synthesis and evaluation of a prototypal artificial red cell
CA Hunt, RR Burnette, RD MacGregor, AE Strubbe, DT Lau, N Taylor, ...
Science 230 (4730), 1165-1168, 1985
1981985
Lymphatic transport of liposome-encapsulated agents: effects of liposome size following intraperitoneal administration
K Hirano, CA Hunt
Journal of pharmaceutical sciences 74 (9), 915-921, 1985
1731985
Synthetic nano-LDL with paclitaxel oleate as a targeted drug delivery vehicle for glioblastoma multiforme
M Nikanjam, AR Gibbs, CA Hunt, TF Budinger, TM Forte
Journal of controlled release 124 (3), 163-171, 2007
1632007
Glucose transport to the brain: a systems model
AA Qutub, CA Hunt
Brain research reviews 49 (3), 595-617, 2005
1232005
The metabolic disposition of radiolabeled enkephalins in vitro and in situ
FB Craves, PY Law, CA Hunt, HH Loh
Journal of Pharmacology and Experimental Therapeutics 206 (2), 492-506, 1978
1161978
Method for producing liposomes in selected size range
CA Hunt, DP Papahadjopoulous
US Patent 4,529,561, 1985
1141985
Engineering targeted in vivo drug delivery. I. The physiological and physicochemical principles governing opportunities and limitations
CA Hunt, RD MacGregor, RA Siegel
Pharmaceutical research 3 (6), 333-344, 1986
1121986
α-Tocopherol retards autoxidation and prolongs the shelf-life of liposomes
CA Hunt, S Tsang
International Journal of Pharmaceutics 8 (2), 101-110, 1981
1111981
Liposome disposition in vivo: effects of pre-dosing with lipsomes.
RM Abra, ME Bosworth, CA Hunt
Research communications in chemical pathology and pharmacology 29 (2), 349-360, 1980
931980
Formation of cysts by alveolar type II cells in three-dimensional culture reveals a novel mechanism for epithelial morphogenesis
W Yu, X Fang, A Ewald, K Wong, CA Hunt, Z Werb, MA Matthay, K Mostov
Molecular biology of the cell 18 (5), 1693-1700, 2007
922007
At the biological modeling and simulation frontier
CA Hunt, GEP Ropella, TN Lam, J Tang, SHJ Kim, JA Engelberg, ...
Pharmaceutical research 26 (11), 2369-2400, 2009
892009
Retention of cytosine arabinoside in mouse lung following intravenous administration in liposomes of different size.
CA Hunt, YM Rustum, E Mayhew, D Papahadjopoulos
Drug Metabolism and Disposition 7 (3), 124-128, 1979
881979
Pharmacokinetics of Δ9-tetrahydrocannabinol in dogs
ER Garrett, CA Hunt
Journal of pharmaceutical sciences 66 (3), 395-407, 1977
861977
Characteristics of oligonucleotide uptake in human keratinocyte cultures
SB Noonberg, MR Garovoy, CA Hunt
Journal of investigative dermatology 101 (5), 727-731, 1993
851993
In vivo generation of highly abundant sequence-specific oligonucleotides for antisense and triplex gene regulation
SB Noonberg, GK Scott, MR Garovoy, CC Benz, CA Hunt
Nucleic acids research 22 (14), 2830-2836, 1994
801994
The system can't perform the operation now. Try again later.
Articles 1–20